JD Supra10m
FDA in focus: 2024 in review and 2025 outlook
In 2024, the Food and Drug Administration (FDA) significantly invested in reorganizing its internal infrastructure and enhancing operations.
STAT28m
At hearing, Makary nods to MAHA’s goals but says little about basic FDA policies
Marty Makary took the opportunity to play the Make America Healthy Again movement’s greatest hits at his Senate confirmation ...